Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HTR1E | P28566 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2082451 | 0.93 | HSD17B10 (0.47) | HSD17B10ACHEMAPK1ALDH1A1LMNA | |
| SCHEMBL10978752 | 0.82 | MAPK1 (0.67) | MAPK1ALDH1A1LMNAMAPTPOLB | |
| SCHEMBL10453479 | 0.77 | MAPT (0.39) | HSD17B10ACHEMAPK1ALDH1A1LMNA | |
| SCHEMBL17596778 | 0.76 | HSD17B10 (0.48) | HSD17B10ACHEMAPK1ALDH1A1LMNA | |
| SCHEMBL10864966 | 0.76 | ESPL1 (0.42) | HSD17B10ACHEMAPK1ALDH1A1LMNA | |
| SCHEMBL27805323 | 0.76 | HSD17B10 (0.48) | HSD17B10ACHEMAPK1ALDH1A1LMNA | |
| SCHEMBL2084708 | 0.75 | SLC6A2 (0.40) | HSD17B10ACHEMAPK1ALDH1A1LMNA | |
| SCHEMBL9017957 | 0.75 | NPC1 (0.41) | MAPK1ALDH1A1LMNAMAPTHTR1E | |
| SCHEMBL29054794 | 0.73 | MAPT (0.39) | HSD17B10ACHEMAPK1ALDH1A1LMNA | |
| SCHEMBL6650386 | 0.73 | TAAR1 (0.40) | HSD17B10MAPK1ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112927938-B | Electrolyte for aluminum electrolytic capacitor, and electronic device | 深圳市智胜新电子技术有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-112927938-A | Electrolyte for aluminum electrolytic capacitor, and electronic device | 深圳市智胜新电子技术有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-109390156-B | One kind disappears hydrogen agent and preparation method thereof, aluminum electrolytic capacitor electrolyte | 惠州市宙邦化工有限公司 | 2019-11-15 | — | — | CN | claimed |
| CN-109390156-A | One kind disappears hydrogen agent and preparation method thereof, aluminum electrolytic capacitor electrolyte | 惠州市宙邦化工有限公司 | 2019-02-26 | — | — | CN | claimed |
| EP-1611120-A4 | NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | CORTICAL PTY LTD (AU) | 2008-04-23 | — | — | EP | claimed |
| US-20070010563-A1 | Novel methods for the treatment of inflammatory diseases | CORTICAL PTY LTD (AU) | 2007-01-11 | — | — | US | claimed |
| EP-1611120-A1 | NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Cortical Pty Ltd (AU) | 2006-01-04 | — | — | EP | claimed |
| WO-2004089927-A1 | NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | CORTICAL PTY LTD (AU) | 2004-10-21 | — | — | WO | claimed |
| CN-112927938-B | Electrolyte for aluminum electrolytic capacitor, and electronic device | 深圳市智胜新电子技术有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-112927938-A | Electrolyte for aluminum electrolytic capacitor, and electronic device | 深圳市智胜新电子技术有限公司 | 2021-06-08 | — | — | CN | disclosed |
| CN-109390156-B | One kind disappears hydrogen agent and preparation method thereof, aluminum electrolytic capacitor electrolyte | 惠州市宙邦化工有限公司 | 2019-11-15 | — | — | CN | disclosed |
| CN-109390156-A | One kind disappears hydrogen agent and preparation method thereof, aluminum electrolytic capacitor electrolyte | 惠州市宙邦化工有限公司 | 2019-02-26 | — | — | CN | disclosed |
| US-7863313-B2 | Methods for the treatment of inflammatory diseases | CORTICAL PTY LTD (AU) | 2011-01-04 | — | — | US | disclosed |
| US-7863313-B2 | Methods for the treatment of inflammatory diseases | CORTICAL PTY LTD (AU) | 2011-01-04 | — | — | US | disclosed |
| EP-1611120-A4 | NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | CORTICAL PTY LTD (AU) | 2008-04-23 | — | — | EP | disclosed |
| US-20070010563-A1 | Novel methods for the treatment of inflammatory diseases | CORTICAL PTY LTD (AU) | 2007-01-11 | — | — | US | disclosed |
| US-20070010563-A1 | Novel methods for the treatment of inflammatory diseases | CORTICAL PTY LTD (AU) | 2007-01-11 | — | — | US | disclosed |
| US-20070010563-A1 | Novel methods for the treatment of inflammatory diseases | CORTICAL PTY LTD (AU) | 2007-01-11 | — | — | US | disclosed |
| EP-1611120-A1 | NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Cortical Pty Ltd (AU) | 2006-01-04 | — | — | EP | disclosed |
| WO-2004089927-A1 | NOVEL METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASES | CORTICAL PTY LTD (AU) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010563-A1 | Novel methods for the treatment of inflammatory diseases | MIF, CCL2, CCL11 | HSD17B10 1623/4885ACHE 3239/4885MAPK1 594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.